Michal Mahdal - Search Results

Year	Number of Results
2021	2
2022	2
2023	4

1

Outcomes of Intercalary Endoprostheses as a Treatment for Metastases in the Femoral and Humeral Diaphysis.

Mahdal M, Pazourek L, Apostolopoulos V, Adámková Krákorová D, Staniczková Zambo I, Tomáš T. Mahdal M, et al. Curr Oncol. 2022 May 13;29(5):3519-3530. doi: 10.3390/curroncol29050284. Curr Oncol. 2022. PMID: 35621674 Free PMC article.

2

Total elbow replacement for giant-cell tumor of bone after denosumab treatment: a case report.

Apostolopoulos V, Tomáš T, Pazourek L, Mahdal M. Apostolopoulos V, et al. Among authors: mahdal m. JSES Int. 2023 Feb 11;7(3):511-515. doi: 10.1016/j.jseint.2023.01.007. eCollection 2023 May. JSES Int. 2023. PMID: 37266166 Free PMC article. No abstract available.

3

Biomechanical analysis of all-polyethylene total knee arthroplasty on periprosthetic tibia using the finite element method.

Apostolopoulos V, Tomáš T, Boháč P, Marcián P, Mahdal M, Valoušek T, Janíček P, Nachtnebl L. Apostolopoulos V, et al. Among authors: mahdal m. Comput Methods Programs Biomed. 2022 Jun;220:106834. doi: 10.1016/j.cmpb.2022.106834. Epub 2022 Apr 25. Comput Methods Programs Biomed. 2022. PMID: 35490458 Free article.

4

Clinical outcomes and survival comparison between NexGen all-poly and its metal-backed equivalent in total knee arthroplasty.

Apostolopoulos V, Nachtnebl L, Mahdal M, Pazourek L, Boháč P, Janíček P, Tomáš T. Apostolopoulos V, et al. Among authors: mahdal m. Int Orthop. 2023 Sep;47(9):2207-2213. doi: 10.1007/s00264-023-05772-3. Epub 2023 Apr 18. Int Orthop. 2023. PMID: 37069277 Free PMC article.

5

Targeted treatment of severe vascular malformations harboring PIK3CA and TEK mutations with alpelisib is highly effective with limited toxicity.

Sterba M, Pokorna P, Faberova R, Pinkova B, Skotakova J, Seehofnerova A, Blatny J, Janigova L, Koskova O, Palova H, Mahdal M, Pazourek L, Jabandziev P, Slaby O, Mudry P, Sterba J. Sterba M, et al. Among authors: mahdal m. Sci Rep. 2023 Jun 28;13(1):10499. doi: 10.1038/s41598-023-37468-4. Sci Rep. 2023. PMID: 37380669 Free PMC article.

6

Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy - Observational prospective single institution analysis.

Múdry P, Kýr M, Rohleder O, Mahdal M, Staniczková Zambo I, Ježová M, Tomáš T, Štěrba J. Múdry P, et al. Among authors: mahdal m. J Bone Oncol. 2021 Apr 7;28:100362. doi: 10.1016/j.jbo.2021.100362. eCollection 2021 Jun. J Bone Oncol. 2021. PMID: 33948428 Free PMC article.

7

New Target for Precision Medicine Treatment of Giant-Cell Tumor of Bone: Sunitinib Is Effective in the Treatment of Neoplastic Stromal Cells with Activated PDGFRβ Signaling.

Mahdal M, Neradil J, Mudry P, Paukovcekova S, Staniczkova Zambo I, Urban J, Macsek P, Pazourek L, Tomas T, Veselska R. Mahdal M, et al. Cancers (Basel). 2021 Jul 15;13(14):3543. doi: 10.3390/cancers13143543. Cancers (Basel). 2021. PMID: 34298757 Free PMC article.

8

Proximal Tibia Tumour Location and Curettage Are Major Risk Factors of Local Recurrence in Giant Cell Tumour of Bone.

Mahdal M, Tomáš T, Apostolopoulos V, Adámková D, Múdry P, Staniczková Zambo I, Pazourek L. Mahdal M, et al. Cancers (Basel). 2023 Sep 21;15(18):4664. doi: 10.3390/cancers15184664. Cancers (Basel). 2023. PMID: 37760632 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

8 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year